| Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|
 Filter
|
TXT
|
Medhanie Assmelash Mulaw
|
||||||
| GSE189756 |
RBPJ deficiency sensitizes pancreatic acinar cells to Kras-mediated PanIN initiation
|
30 |
|
Medhanie Assmelash Mulaw | Oct 03, 2023 | |||
| GSE241812 |
Skeletal muscle gene expression analysis of Shank3Δ11(-/-) and wildtype mice at postnatal day 0–1
|
9 |
|
Medhanie Assmelash Mulaw | Aug 30, 2023 | |||
| GSE215059 |
Bilineal differentiated liver carcinoma cells generates highly aggressive escape variants
|
12 |
|
Medhanie Assmelash Mulaw | May 23, 2023 | |||
| GSE210352 |
Identification of a glycosphingolipid+ immune regulatory innate-like CD8 T-cell network in old mice
|
38 |
|
Medhanie Assmelash Mulaw | May 22, 2023 | |||
| GSE225267 |
pH regulates hematopoietic stem cell potential via polyamines
|
18 |
|
Medhanie Assmelash Mulaw | Feb 24, 2023 | |||
| GSE200536 |
Reduced adhesion of aged intestinal stem cells contributes to an accelerated clonal drift
|
1920 |
|
Medhanie Assmelash Mulaw | Apr 27, 2022 | |||
| GSE167214 |
Attrition of X chromosome inactivation in aged hematopoietic stem cells
|
6 |
|
Medhanie Assmelash Mulaw | Apr 07, 2021 | |||
| GSE158140 |
Repolarization of HSC attenuates HSCs failure in Shwachman-Diamond syndrome
|
79 |
|
Medhanie Assmelash Mulaw | Sep 18, 2020 | |||
| GSE140397 |
IFNγ treatment restores TAP-dependent presentation competence of PD-L1 sensitive PDAC cells
|
10 |
|
Medhanie Assmelash Mulaw | Aug 06, 2020 | |||
| GSE119466 |
LaminA/C regulates epigenetic and chromatin architecture changes upon aging of hematopoietic stem cells
|
12 |
|
Medhanie Assmelash Mulaw | Sep 05, 2018 | |||
| GSE107007 |
Aged Hematopoietic Stem Cells Drive Aging-Associated Immune Remodeling
|
18 |
|
Medhanie Assmelash Mulaw | Jun 12, 2018 | |||
| GSE81321 |
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [ChIP-Seq]
|
2 | Medhanie Assmelash Mulaw | Jul 04, 2016 | ||||
| GSE81328 |
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human]
|
8 |
|
Medhanie Assmelash Mulaw | Jul 04, 2016 | |||
| GSE81329 |
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq mouse]
|
8 |
|
Medhanie Assmelash Mulaw | Jul 04, 2016 | |||
| GSE81330 |
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML
|
36 | Medhanie Assmelash Mulaw | Jul 04, 2016 |
